Chuanxin Biomedical (Suzhou) Co., Ltd. announced that it has received CNY 150,000,000 in a round of funding on June 29, 2023. The transaction included participation from new investor Changchun BCHT Biotechnology Co.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
30.05 CNY | -3.35% |
|
+6.03% | -45.17% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.17% | 1.77B | |
+4.09% | 70.89B | |
+16.90% | 9.08B | |
+11.92% | 4.53B | |
-21.91% | 4.47B | |
+22.70% | 3.97B | |
+2.19% | 2.08B | |
+11.95% | 2.04B | |
-36.00% | 1.94B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 688276 Stock
- News Changchun BCHT Biotechnology Co.
- Chuanxin Biomedical Co., Ltd. announced that it has received CNY 150 million in funding from Changchun BCHT Biotechnology Co.